Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $195,238 - $221,796
-4,643 Reduced 19.66%
18,978 $833,000
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $367,943 - $436,630
-9,146 Reduced 27.91%
23,621 $1.04 Million
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $97,044 - $113,093
-2,496 Reduced 7.08%
32,767 $1.46 Million
Q3 2021

Nov 15, 2021

BUY
$38.79 - $43.16 $117,650 - $130,904
3,033 Added 9.41%
35,263 $1.37 Million
Q2 2021

Aug 16, 2021

BUY
$36.52 - $41.46 $330,359 - $375,047
9,046 Added 39.02%
32,230 $1.3 Million
Q1 2021

May 17, 2021

BUY
$34.27 - $40.01 $197,086 - $230,097
5,751 Added 32.99%
23,184 $828,000
Q4 2020

Feb 16, 2021

BUY
$34.07 - $39.94 $207,520 - $243,274
6,091 Added 53.7%
17,433 $647,000
Q3 2020

Nov 16, 2020

BUY
$38.11 - $42.99 $166,693 - $188,038
4,374 Added 62.77%
11,342 $430,000
Q2 2020

Aug 14, 2020

SELL
$37.87 - $43.58 $331,135 - $381,063
-8,744 Reduced 55.65%
6,968 $290,000
Q1 2020

May 15, 2020

SELL
$32.47 - $48.83 $185,630 - $279,161
-5,717 Reduced 26.68%
15,712 $604,000
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $8,610 - $9,891
-205 Reduced 0.95%
21,429 $1.01 Million
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $24,721 - $26,590
611 Added 2.91%
21,634 $929,000
Q2 2019

Aug 14, 2019

SELL
$39.4 - $42.7 $352,078 - $381,567
-8,936 Reduced 29.83%
21,023 $849,000
Q4 2018

Feb 14, 2019

BUY
$37.8 - $42.69 $20,260 - $22,881
536 Added 1.82%
29,959 $1.16 Million
Q3 2018

Nov 14, 2018

SELL
$39.75 - $42.69 $225,939 - $242,649
-5,684 Reduced 16.19%
29,423 $1.19 Million
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $9,189 - $9,920
232 Added 0.67%
35,107 $1.43 Million
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $64,400 - $71,467
1,780 Added 5.38%
34,875 $1.38 Million
Q4 2017

Feb 14, 2018

BUY
$35.34 - $41.9 $341,455 - $404,837
9,662 Added 41.23%
33,095 $1.18 Million
Q3 2017

Nov 14, 2017

BUY
$39.44 - $41.55 $924,197 - $973,641
23,433
23,433 $958,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Greytown Advisors Inc. Portfolio

Follow Greytown Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.